Zhejiang Cheng Yi Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Zhejiang Cheng Yi Pharmaceutical Co Ltd working capital to net assets ratio. Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Working Capital to Net Assets ratio of 12.7% as of June 2026. Working capital of CN¥180.72 Million (current assets of CN¥447.42 Million minus current liabilities of CN¥266.70 Million) is measured against net assets of CN¥1.43 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Zhejiang Cheng Yi Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Working capital to net assets ratio of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Zhejiang Cheng Yi Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 12.7%, reflecting working capital of CN¥180.72 Million against net assets of CN¥1.43 Billion CNY. See Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) liquidity interval to measure how many days the company can operate on defensive assets alone.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2011–2025)
Zhejiang Cheng Yi Pharmaceutical Co Ltd working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Zhejiang Cheng Yi Pharmaceutical Co Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.2% | CN¥129.16 Million | CN¥1.40 Billion | CN¥395.49 Million | CN¥266.33 Million | ▲ +1.2 pp |
| 2024 | 8.1% | CN¥102.12 Million | CN¥1.27 Billion | CN¥393.62 Million | CN¥291.50 Million | ▼ -6.5 pp |
| 2023 | 14.6% | CN¥174.78 Million | CN¥1.20 Billion | CN¥517.42 Million | CN¥342.65 Million | ▼ -1.8 pp |
| 2022 | 16.4% | CN¥178.85 Million | CN¥1.09 Billion | CN¥436.84 Million | CN¥257.99 Million | ▲ +12.3 pp |
| 2021 | 4.1% | CN¥40.93 Million | CN¥998.88 Million | CN¥287.80 Million | CN¥246.87 Million | ▼ -2.1 pp |
| 2020 | 6.2% | CN¥54.93 Million | CN¥886.09 Million | CN¥282.31 Million | CN¥227.38 Million | ▼ -8.8 pp |
| 2019 | 15.0% | CN¥114.98 Million | CN¥768.96 Million | CN¥317.18 Million | CN¥202.20 Million | ▼ -15.7 pp |
| 2018 | 30.6% | CN¥206.25 Million | CN¥673.54 Million | CN¥343.82 Million | CN¥137.57 Million | ▼ -35.5 pp |
| 2017 | 66.1% | CN¥396.34 Million | CN¥599.57 Million | CN¥467.23 Million | CN¥70.88 Million | ▲ +30.7 pp |
| 2016 | 35.4% | CN¥99.25 Million | CN¥280.17 Million | CN¥181.00 Million | CN¥81.75 Million | ▲ +3.4 pp |
| 2015 | 32.0% | CN¥83.26 Million | CN¥259.92 Million | CN¥167.71 Million | CN¥84.45 Million | ▲ +5.0 pp |
| 2014 | 27.1% | CN¥66.85 Million | CN¥246.95 Million | CN¥147.96 Million | CN¥81.11 Million | ▲ +10.4 pp |
| 2013 | 16.6% | CN¥33.49 Million | CN¥201.40 Million | CN¥165.32 Million | CN¥131.83 Million | ▲ +0.8 pp |
| 2012 | 15.8% | CN¥28.19 Million | CN¥178.13 Million | CN¥207.54 Million | CN¥179.35 Million | ▲ +56.1 pp |
| 2011 | -40.3% | CN¥-41.34 Million | CN¥102.60 Million | CN¥151.22 Million | CN¥192.56 Million | — |